- Boston Scientific (BSX) has agreed to acquire Bayer's (BAYRY) Interventional device business for $415M.
- The deal that will strengthen Boston's portfolio of products for treating peripheral vascular disease, with the company to receive systems used in cardiology, radiology and peripheral vascular procedures.
- The unit generated $120M in sales last year. (PR)
From other sites
at Zacks.com (Apr 7, 2015)
at Zacks.com (Mar 26, 2015)
Boston Scientific : Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Deviceat 4-traders.com (Mar 24, 2015)
Boston Scientific : Announces First U.S. Commercial Procedures With The WATCHMAN(TM) Left Atrial Appendage Closure Deviceat 4-traders.com (Mar 24, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs